Zynerba Pharmaceuticals

zynerba.com ↗
#13 in Pharma Tech

Zynerba Pharmaceuticals is developing novel transdermal cannabinoid therapies. Their lead candidate, ZYN002 (Zygel™), has shown success in mid-stage trials for Fragile X Syndrome, leading to positive community reactions and stock performance. The company focuses on delivering therapeutic cannabinoids through a topical gel for various conditions.

Visit Zynerba Pharmaceuticals Website ↗

What is Zynerba Pharmaceuticals?

Zynerba Pharmaceuticals is developing novel transdermal cannabinoid therapies. Their lead candidate, ZYN002 (Zygel™), has shown success in mid-stage trials for Fragile X Syndrome, leading to positive community reactions and stock performance. The company focuses on delivering therapeutic cannabinoids through a topical gel for various conditions. Based on 5 Reddit mentions across 3 subreddits, Zynerba Pharmaceuticals has a 20% positive sentiment score in the Pharma Tech space. Reddit users most frequently discuss Zynerba Pharmaceuticals in r/weedstocks.

Last scanned 22 days ago

0 Mentions (30 days)
0 Mentions (90 days)
5 Total Mentions
New 30-Day Trend

Sentiment Breakdown

Positive
20%
Neutral
80%
Negative
0%

Top Subreddits

What Reddit Praises

What Redditors Are Saying

"Zynerba's lead candidate ZYN002 successful in mid-stage Fragile X study; shares ahead 96% premarket"

"HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC. - Zynerba"

"Zynerba Pharmaceuticals Reports Third Quarter 2017 Financial Results and Operational Highlights"

Other Pharma Tech Companies on Reddit

Track Zynerba Pharmaceuticals's Reddit presence in real-time

Get alerts when Zynerba Pharmaceuticals is mentioned on Reddit and respond before competitors do.

Start Free Trial